Treatment of cytomegalovirus retinitis in AIDS with an intraocular sustained-release ganciclovir implant

Active cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome (AIDS) was treated with an intraocular sustained-release ganciclovir implant. A total number of 19 implants were performed in 15 eyes of 9 AIDS patients. The intraocular sustained-release ganciclovir was effec...

Full description

Saved in:
Bibliographic Details
Published inNippon Ganka Gakkai zasshi Vol. 102; no. 8; p. 515
Main Authors Mochizuki, M, Ikeda, E, Yoshimura, K, Hikita, N, Nagata, Y, Iwamoto, A, Fujino, Y, Eguchi, S, Oka, S, Kimura, S
Format Journal Article
LanguageJapanese
Published Japan 01.08.1998
Subjects
Acquired Immunodeficiency Syndrome - complications
Adult
AIDS-Related Opportunistic Infections - drug therapy
Antiviral Agents - administration & dosage
Cytomegalovirus Retinitis - drug therapy
Delayed-Action Preparations
Drug Implants
Ganciclovir - administration & dosage
Humans
Lens, Crystalline
Male
Middle Aged
Online AccessGet more information

Cover

More Information
Summary:Active cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome (AIDS) was treated with an intraocular sustained-release ganciclovir implant. A total number of 19 implants were performed in 15 eyes of 9 AIDS patients. The intraocular sustained-release ganciclovir was effective in preventing reactivation of CMV retinitis in 15 of the 19 implants, ineffective in 3, and undetermined in 1. All ineffective cases had been resistant to ganciclovir therapy before the implants. Vision after the therapy was maintained at better than 0.5 except for one eye. There were no serious ocular complications caused by the therapy. Among 5 patients with unilateral CMV retinitis, 2 unaffected eyes developed CMV retinitis during this therapy. In addition, another patient developed presumed CMV infection in other systemic organs. Based on these data, the intraocular sustained-release ganciclovir implant was considered to be useful for the treatment of CMV retinitis in AIDS.
ISSN:0029-0203